Project 836
$0.6MFY2027 request ▲ 2%Field Medical Systems Advanced Development
FY2025 actual$0.2M
FY2026 enacted$0.6M
FY2027 request$0.6M
Management ServicesProduct DevelopmentSupportTest and Evaluation
FY2027 Request
$1.0M
▲ 1.7% vs FY2026
FY2026 Enacted
$1.0M
▲ 72% vs FY2025
FY2025 Actual
$0.6M
Prior year
Roll-up of 2 projects. Projects are the summable leaves — the PE total is their sum, never added to it.
For fiscal year 2027, the U.S. Army is requesting $1.0M for Medical Systems - Adv Dev under RDT&E program element 0603807A, up 1.7% over FY2026.
Funding trajectory
Funding profile, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure.
Actual Enacted Request Outyear (FYDP)
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 0.6 |
| FY2026 | Enacted | 1.0 |
| FY2027 | Request | 1.0 |
| FY2028 | Outyear | 1.0 |
| FY2029 | Outyear | 1.0 |
| FY2030 | Outyear | 1.0 |
| FY2031 | Outyear | 1.0 |
Where it sits
Acquisition lifecycle
This program is funded in RDT&E Budget Activity 4 — Advanced Component Development & Prototypes.
Complete
Research
BA 1–2
Complete
Advanced Technology
BA 3
Current
Prototyping
BA 4
Later
Development & Fielding
BA 5–7
Inside the program element
2 projects roll up into PE 0603807A
Projects are the summable leaves — the PE total is their sum, never added to it. Program elements and projects carry the full five-year plan; activities stop at the budget year. This PE moves 2% overall, which can hide much larger swings below.
Project 808
$0.4MFY2027 request ▲ 2%DoD Drug & Vacc Ad
FY2025 actual$0.4M
FY2026 enacted$0.4M
FY2027 request$0.4M
Management Services
Congressional action
Congressional marks
Committee marks on the FY2027 request. Adds and cuts are reconciled in conference before they become law.
RequestPresident's Budget
$1.0M
House NDAA (HASC)HASC
$1.0M full · +$0
Senate NDAA (SASC)SASC
$1.0M full · +$0
House Approps (HAC-D)HAC_D
$1.0M full · +$0
unresolved as of 2026-07-27. These are FY2027 authorization marks (NDAA); appropriations and the conference agreement may differ.
Who's building it
Where the FY2027 request goes
Performers named in the R-3 exhibit, resolved into industry, government-lab, and unspecified shares. Budget-justification contract funding, not obligations.
Not Applicable
$0.6M · 54%
| Where FY2027 funding flows | Share | $M |
|---|---|---|
| Industry primes | 54% | 0.6 |
| Other / unspecified | 46% | 0.5 |
| FY2027 request | 100% | 1.0 |
Program detail
Mission & acquisition strategy
This Program Element (PE) provides funding for the development of medical materiel during the early system integration phase of the System Development and Demonstration stage within the acquisition life cycle, utilizing 6.4 Advanced Component Development and Prototype funding. These efforts are critical to advancing medical technologies that address the Army's future force requirements and operational readiness.
The Acquisition Strategy is designed to support the development, testing, and evaluation of advanced medical technologies and systems that are approaching the transition from research and development to operational use. Utilizing 6.4 Advanced Component Development and Prototype funding, the strategy prioritizes refining prototypes, conducting system integration, and ensuring that medical solutions are fully prepared for field deployment to support U.S. Army Forces. These efforts are critical to enhancing readiness, improving survivability, and addressing capability gaps within the Army's medical modernization framework.
Project 836, 808 — Field Medical Systems Advanced Development
- Management Services
- Product Development
- Support
- Test and Evaluation
Ask Hitch
Ask this program element
Answers are generated from the figures on this page — the FY2027 justification exhibits and the marks tracked above — and nothing else is consulted. Confirm any figure against the cited exhibit before you use it externally.
H
Questions this page can answer
How does the FY2027 request compare with FY2026, and what does the five-year plan show?What did the FY2027 NDAA committees do to this request?Which project inside PE 0603807A is growing fastest, and which is shrinking?How is the FY2027 request split between industry and government performers?
This page carries the budget justification and the NDAA marks — nothing else. For what Not Applicable has actually been obligated, the ledger is at hitchintel.com/vendors; for live solicitations, hitchintel.com/opportunities. Both are member surfaces.
Provenance
Cite this page
Sources
FY2027 Department of the Army RDT&E Budget Justification · Exhibits R-2 / R-3 · PE 0603807A (President's Budget PB2027) — and FY2027 NDAA committee marks, as tracked 2026-07-27.
Suggested citation
HitchAI, "Medical Systems - Adv Dev (PE 0603807A)," federal budget intelligence, PB2027 vintage. hitchintel.com/programs/0603807A
Machine access
Markdown twin
/programs/0603807A.md · MCP mcp.hitchintel.com → budget_get_program_element, budget_get_cong_marksFY2027 Request
$0.6M
▲ 1.7% vs FY2026
FY2026 Enacted
$0.6M
▲ 261% vs FY2025
FY2025 Actual
$0.2M
Prior year
Field Medical Systems Advanced Development — one RDT&E project inside PE 0603807A. Congressional marks are recorded on the program element, not on a project.
Project 836 — Field Medical Systems Advanced Development — requests $0.6M in FY2027, 58% of the $1.0M requested for program element 0603807A. Year over year it grows 1.7% against FY2026.
Funding trajectory
Project 836 funding, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.
Actual Enacted Request Outyear (FYDP)
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 0.2 |
| FY2026 | Enacted | 0.6 |
| FY2027 | Request | 0.6 |
| FY2028 | Outyear | 0.6 |
| FY2029 | Outyear | 0.6 |
| FY2030 | Outyear | 0.6 |
| FY2031 | Outyear | 0.6 |
Inside the project
1 accomplishment / planned program
The R-2A exhibit. Activities carry the prior, current and budget year only — no five-year plan — and they are descriptive: coverage is partial and they do not always add back to the project, so count them, never total them.
Field Medical Systems Advanced Development - Medical Readiness▲ 2%
FY2025 actual$0.2M
FY2026 enacted$0.6M
FY2027 request$0.6M
FY2027 planned work Continue to provide development support and conduct in-depth analysis of medical device component integration into mobile platforms and shelters. This effort focuses on enhancing the operational capabilities of deployable medical systems, ensuring they are equipped to deliver advanced care in austere and dynamic environments. By integrating cutting-edge medical technologies into mobile platforms, we aim to improve the efficiency, reliability, and adaptability of medical shelters, enabling them to better support the health and readiness of military personnel during mission. The development and integration of medical devices into mobile platforms, combined with the advancement of the BOSS…
FY2026 to FY2027 change Increase from FY26 to FY27 will enhance Advanced Development efforts for Blast Overpressure Sensor System (BOSS): Enhancing Soldier Health Monitoring.
FY2026 plans — current year Mobile Medical Platforms and Shelters (formerly Division Medical Mobile Shelter (DMMS)): Continue development support and analysis of Medical Device component integration into Mobile platforms and shelters. Blast Overpressure Sensor System (BOSS): Progress in developing a sensing capability to collect blast overpressure (BOP) data from soldiers. Monitoring capability that will collect, integrate, store, and transmit BOP exposure data within the Army enterprise and DoW information system databases to provide a longitudinal record of BOP exposures to aide in understanding and tracking potential long-term health consequences of repeated BOP exposure.
FY2025 accomplishments Division Medical Mobile Shelter (DMMS): Begin evaluating commercial infrastructure equipment and development of DMMS. Blast Overpressure Sensor System (BOSS): develop a sensing capability to collect blast overpressure (BOP) data from soldiers.
Who's building it
Named performers on project 836
Performers named in the R-3 exhibit under this project. Share is of the project's whole FY2027 R-3 total — the same denominator the program-element split uses, so the two read on one scale and will not sum to 100% when unnamed or government work is in the mix. Budget-justification contract funding, not obligations.
Not Applicable
$0.1M · 20%
Project detail
What project 836 buys
This project line is critical to equipping deployable forces with advanced medical systems that improve health outcomes, enhance operational effectiveness, and sustain Soldier readiness in the most challenging environments. By investing in engineering, manufacturing, and testing, the initiative ensures that lifesaving medical technologies are field-ready and capable of meeting the demands of modern warfare. Through innovation and collaboration, this effort strengthens the Army's ability to provide comprehensive medical support, ensuring the well-being and survivability of Soldiers while enhancing the overall effectiveness of battlefield operations. Products from this project will transition to PE 0604807A (Medical Materiel/Medical Biological Defense Equipment - Eng Dev) /Project 832 (Field Medical Systems Engineering Development). The Blast Overpressure Sensor System (BOSS) project will address tactical integration, product development, data management, medical record integration, operational testing and evaluation. The BOSS effort requires more in-depth tactical network integration in order to transfer data from the sensor to the data repository and eventually to the medical record.
R-3 lines of work
- Management Services
- Product Development
- Support
- Test and Evaluation
FY2027 Request
$0.4M
▲ 1.7% vs FY2026
FY2026 Enacted
$0.4M
▲ 0.2% vs FY2025
FY2025 Actual
$0.4M
Prior year
DoD Drug & Vacc Ad — one RDT&E project inside PE 0603807A. Congressional marks are recorded on the program element, not on a project.
Project 808 — DoD Drug & Vacc Ad — requests $0.4M in FY2027, 42% of the $1.0M requested for program element 0603807A. Year over year it grows 1.7% against FY2026.
Funding trajectory
Project 808 funding, FY2025–FY2031
Prior years are actuals, the budget year is the request, and the outyears are the FYDP plan. Estimate types are colored and never summed into one figure. Projects carry the full five-year plan; the activities inside them stop at the budget year.
Actual Enacted Request Outyear (FYDP)
| Fiscal Year | Estimate Type | Amount ($M) |
|---|---|---|
| FY2025 | Actual | 0.4 |
| FY2026 | Enacted | 0.4 |
| FY2027 | Request | 0.4 |
| FY2028 | Outyear | 0.4 |
| FY2029 | Outyear | 0.4 |
| FY2030 | Outyear | 0.4 |
| FY2031 | Outyear | 0.4 |
Inside the project
1 accomplishment / planned program
The R-2A exhibit. Activities carry the prior, current and budget year only — no five-year plan — and they are descriptive: coverage is partial and they do not always add back to the project, so count them, never total them.
DoD Drug and Vaccine Advanced Development - Medical Readiness▲ 2%
FY2025 actual$0.4M
FY2026 enacted$0.4M
FY2027 request$0.4M
FY2027 planned work Resources are directed toward advancing the modernization of medical devices through collaboration with external stakeholders. These partnerships facilitate the integration of innovative technologies and solutions into the acquisition process, ensuring that medical devices meet the evolving needs of military personnel and align with operational requirements. By investing in these initiatives, we strengthen the ability to prevent and respond to infectious diseases, improve health outcomes, and enhance the overall readiness and resilience of the Warfighter.
FY2026 to FY2027 change Increased funding from FY26 to FY27 will support advanced development support for acquisition products that will enhance the Warfighters capability.
FY2026 plans — current year Continue to provide Civilian Manpower support for Project Manager Soldier Medical Devices (PM SMD, formerly known as Medical Field Systems PMO)
FY2025 accomplishments Provided Civilian Manpower support for Medical Field Systems Project Management Office (MFS PMO, formerly known as Warfighter Health, Performance and Evacuation PMO).
Who's building it
Named performers on project 808
Performers named in the R-3 exhibit under this project. Share is of the project's whole FY2027 R-3 total — the same denominator the program-element split uses, so the two read on one scale and will not sum to 100% when unnamed or government work is in the mix. Budget-justification contract funding, not obligations.
Not Applicable
$0.4M · 100%
Project detail
What project 808 buys
Project funds will applied to strategically address future force requirements identified in concept documents and organizational structures. PM SMD leverages this funding to develop and integrate advanced medical solutions that enhance Warfighter survivability and operational effectiveness in support of Capability Program Executive Ground (Soldier Systems). These efforts ensure the Army remains equipped with cutting-edge medical technologies to meet the demands of modern and future combat environments. This Program Element represents a vital investment in the Army's medical modernization strategy, enabling the development and fielding of innovative medical solutions that align with the Army's readiness priorities and sustain the health and effectiveness of the force. These funds have transitioned from T2COM (AFC) into ASA(ALT) starting FY26. Requesting project 808 / DoD Drug & Vacc Ad funding to be merged into 836 / Field Medical Systems Advanced Development. This will benefit the development, testing, and evaluation of advanced medical technologies and systems that are nearing the transition from research and development to operational use. Our primary focus of utilizing this 6.4 funding is on refining prototypes, conducting system integration, and ensuring that medical solutions are ready for field deployment for US Army Forces.
R-3 lines of work
- Management Services